Quick Takeaways
- NCEL - NewcelX Ltd. has 9 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
- Info
- Insider Trading
- Financials
Insider Transactions Reported by 9 Insiders of NewcelX Ltd.
- Symbol
- NCEL on Nasdaq
- Location
- Zurich
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 23 Apr 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
NewcelX Ltd. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michel Revel | CSO and Director, Director | $2,700,058 | Mixed | 18 Mar 2026 | ||
| Ronen Twito | Chairman and CEO, Director | $781,785 | Mixed | 18 Mar 2026 | ||
| Tamar Galili | Director | Mixed | 18 Mar 2026 | |||
| Eran Israel Iohan | Director | Mixed | 18 Mar 2026 | |||
| Liora Oren | Director | Mixed | 18 Mar 2026 | |||
| Olivier Samuel | Director | Mixed | 18 Mar 2026 | |||
| Omri Hagai | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Alexander Zwyer | Director | Mixed | 18 Mar 2026 | |||
| Kfir Molakandov | VP of R&D | Mixed | 18 Mar 2026 |
Top shareholders of NewcelX Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Michel Revel |
3/4/5
13D/G
|
CSO and Director, Director |
20%
from 13D/G
|
940,787
|
$2,700,058 | — | 18 Mar 2026 | |
| Ronen Twito |
3/4/5
13D/G
|
Chairman and CEO, Director |
6%
from 13D/G
|
272,399
|
$781,785 | — | 18 Mar 2026 | |
| Lind Global Fund II LP |
13D/G
|
— |
4.9%
|
59,780
|
$90,866 | $0 | 31 Dec 2024 | |
| CoreCap Advisors, LLC |
13F
|
Company |
0%
|
3
|
$6 | — | 31 Dec 2025 | |
| League Jinn Sarl |
13D/G
|
— |
22%
|
988,996
|
— | $0 | 30 Oct 2025 | |
| Ronald Hafner |
13D/G
|
— |
13%
|
557,131
|
— | $0 | 22 May 2025 | |
| CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP |
13D/G
|
— |
7.5%
|
343,120
|
— | $0 | 30 Oct 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
0.6%
|
28,732
|
— | $0 | 31 Oct 2025 |
Recent Insider Transactions by Companies or Individuals for NewcelX Ltd.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michel Revel | NCEL | Ordinary Shares | 0 | 940,787 | 18 Mar 2026 | Direct | ||||
| Ronen Twito | NCEL | Ordinary Shares | 0 | 272,399 | 18 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.